Tuesday, August 14, 2018
IBB 116.56 0.17 (0.15%)XBI 94.50 0.45 (0.47%)
Ticker Current Price Change Graph
IBB 116.56 0.17 (0.15%)
XBI 94.50 0.45 (0.47%)
Last updated: ago
Sign in to Endpoints
Menu Search
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Endpoints Careers
  • About
  • Advertise
  • Privacy Policy
  • Reader center

Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly

by John Carrollenvelope — on August 13, 2018 10:00 AM EDT
Updated: 10:44 AM

FDA drafts guidance on seamless clinical trials for cancer drug developers

by Zachary Brennan - RAPSenvelope — on August 13, 2018 08:00 AM EDT

Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line

by John Carrollenvelope — on August 13, 2018 07:40 AM EDT
Updated: 10:38 AM

Back to the beginning: Pfizer seeds discovery-stage neuro startup Magnolia (after axing its own brain R&D)

by Brittany Meilingenvelope — on August 13, 2018 06:00 AM EDT
Updated: 08:15 AM

UPDATED: Once stiff-armed at the FDA, new management offers Amicus a warm embrace for Galafold — priced at $315,000

by John Carrollenvelope — on August 10, 2018 04:40 PM EDT
Updated: August 13, 2018 08:49 AM

Gung ho: Alnylam lands historic FDA OK on patisiran, revving up the first global rollout for an RNAi breakthrough

by John Carrollenvelope — on August 10, 2018 12:51 PM EDT
Updated: August 13, 2018 04:34 AM

PARP inhibitors for ALS? Penn researchers post promising finds in brain disease

by Amber Tongenvelope — on August 10, 2018 10:53 AM EDT

Trump administration sinks teeth into paring down drug prices, on 5 key points

by Kaiser Health Newsenvelope — on August 10, 2018 09:03 AM EDT

Pfizer, Novartis jump into an $84M development round for UK cancer drug stars at Artios

by John Carrollenvelope — on August 10, 2018 08:41 AM EDT

China regulators offer VIP treatment for 48 overseas drugs they’re ready to hustle up with accelerated reviews

by Amber Tongenvelope — on August 10, 2018 07:10 AM EDT
Updated: August 13, 2018 04:21 AM

  • 1
  • 2
  • 3
  • 166

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • Endpoints Careers
  • About Endpoints
  • Privacy Policy
  • Advertise/Media Kit

copyright 2018 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign in to Endpoints News

I forgot my password Request a magic link
← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours.
← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours.